Ilya Pharma was granted 3 million euro in the latest Phase 2 round in the Horizon 2020 SME Instrument programme. GAEU Consulting wrote the EU application and guided the research company through the application procedure.
The EU project aims to develop next-generation biological drugs for treating of wounds in skin and mucosa. Through the EU contribution, the company now has the funding secured to reach clinical data with its new drug candidate.
Ms. Evelina Vågesjö, CEO, Ilya Pharma: “The collaboration with GAEU has been very fruitful for Ilya Pharma. The process has been exceptionally well taken care of by GAEU consultants that really have excellent skills for breaking down a complex project in logic activities and get the message through how the different parts are connected. It feels great to have GAEU in the process when delivering project on this 18 month grant”.
Mr. Tomasz Wasik, head of GAEU Horizon 2020 Centre of Excellence:
“Our formula is to start up with an in-depth analysis to figure out if the company has a realistic chance of being a winner. If so, we put together a tailor-made team of experts with high commercial and academic acumen. The application is being produced in good partnerships with our customers. We only use our own personnel”.
Tomasz Wasik, GAEU Consulting, +48696108683, email@example.com
Evelina Vågesjö, vd ILYA Pharma, +46 (0) 70-636 64 94, firstname.lastname@example.org
Pictures for free publication are available in the Press Room at www.gaeu.com
GAEU Consulting is a leading EU grant consultancy, combining high academic standards with strong business acumen. GAEU Horizon 2020 Centre of Excellence in Cracow is one of Europe´s largest privately owned knowledge hubs for Horizon 2020 projects.